{"organizations": [], "uuid": "42014a28163dd6c30862c28dac37cfa33cf8fd50", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://feeds.reuters.com/reuters/companyNews\r", "section_title": "Reuters: Company News", "url": "https://www.reuters.com/article/brief-argos-therapeutics-board-approves/brief-argos-therapeutics-board-approves-one-for-twenty-reverse-split-of-cos-common-stock-effective-jan-18-after-close-idUSASB0C1EF", "country": "US", "domain_rank": 408, "title": "BRIEF-Argos Therapeutics Board Approves One-For-Twenty Reverse Split Of Co's Common Stock Effective Jan 18, After Close", "performance_score": 0, "site": "reuters.com", "participants_count": 0, "title_full": "", "spam_score": 0.0, "site_type": "news", "published": "2018-01-18T15:07:00.000+02:00", "replies_count": 0, "uuid": "42014a28163dd6c30862c28dac37cfa33cf8fd50"}, "author": "", "url": "https://www.reuters.com/article/brief-argos-therapeutics-board-approves/brief-argos-therapeutics-board-approves-one-for-twenty-reverse-split-of-cos-common-stock-effective-jan-18-after-close-idUSASB0C1EF", "ord_in_thread": 0, "title": "BRIEF-Argos Therapeutics Board Approves One-For-Twenty Reverse Split Of Co's Common Stock Effective Jan 18, After Close", "locations": [], "entities": {"persons": [], "locations": [], "organizations": [{"name": "brief-argos therapeutics board approves one-for-twenty reverse split of co", "sentiment": "negative"}, {"name": "brief-argos therapeutics board", "sentiment": "negative"}, {"name": "board", "sentiment": "none"}, {"name": "reuters staff", "sentiment": "none"}, {"name": "reuters", "sentiment": "none"}, {"name": "eikon", "sentiment": "none"}, {"name": "twenty reverse split of co", "sentiment": "none"}, {"name": "argos therapeutics inc", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "January 18, 2018 / 1:09 PM / Updated 10 minutes ago BRIEF-Argos Therapeutics Board Approves One-For-Twenty Reverse Split Of Co's Common Stock Effective Jan 18, After Close Reuters Staff \nJan 18 (Reuters) - Argos Therapeutics Inc: * ARGOS ANNOUNCES ONE-FOR-TWENTY REVERSE STOCK SPLIT \n* ARGOS THERAPEUTICS - BOARD APPROVED ONE-FOR-TWENTY REVERSE SPLIT OF COâ€˜S COMMON STOCK THAT WILL TAKE EFFECT JANUARY 18, AFTER CLOSE OF TRADING Source text for Eikon: Further company coverage:", "external_links": [], "published": "2018-01-18T15:07:00.000+02:00", "crawled": "2018-01-18T15:26:39.030+02:00", "highlightTitle": ""}